Evidence map›Paper›PMID 33842393›Full record

ArticleFrontiers in cellular and infection microbiology2021

The Anti-Inflammatory Effect and Mucosal Barrier Protection of

Yuyuan Li, Man Liu, He Liu, Xue Sui, Yinhui Liu, Xiaoqing Wei, Chunzheng Liu, Yiqin Cheng, Weikang Ye, Binbin Gao and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
  4. Frontiers in immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Influence of CTG repeats from the human DM1 locus on murine gut microbiota.Computational and structural biotechnology journal · 2025
    Article
  11. Article
  12. Observational
  13. Review
  14. Animals : an open access journal from MDPI · 2022
    Article
  15. Article
  16. Annals of translational medicine · 2022
    Article
  17. Article
  18. Frontiers in pharmacology · 2022
    Article
  19. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Yuyuan LiAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Man LiuCollege of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
He LiuCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Xue SuiAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Yinhui LiuCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Xiaoqing WeiCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Chunzheng LiuCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Yiqin ChengCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Weikang YeCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Binbin GaoCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Xin WangCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Qiao LuCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Hao ChengMarketing Department, Hangzhou Grand Biologic Pharmaceutical Inc., Hangzhou, China.
Lu ZhangMarketing Department, Hangzhou Grand Biologic Pharmaceutical Inc., Hangzhou, China.
Jieli YuanCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Ming LiCollege of Basic Medical Science, Dalian Medical University, Dalian, China.
Dalian Medical University · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at determining the beneficial effect of

Indexed as

Clostridium butyricumDysbiosisAnimalsCeftriaxoneIntestinal MucosaIntestinesMiceMice, Inbred BALB CCeftriaxoneCB RH2 in Intestinal DysbiosisClostridium butyricumgut microbiotaimmune responsemucosal barrier function

Identifiers

PMID33842393
PMCPMC8027357
OpenAlexW3142083750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.